DHR
What one share of Danaher holds
Industrial Instruments For Measurement, Display, and Control
Danaher is a global science and technology innovator committed to accelerating the power of science and technology to improve human health. Danaher is comprised of more than 15 operating companies with leadership positions in the biotechnology, life sciences and diagnostics sectors, organized under three segments (Biotechnology, Life Sciences and Diagnostics).
Danaher’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-09-25; the balance sheet is as of 2026-09-25.
| Sales | $36.12 |
|---|---|
| Profit | $6.11 |
| Capex (buildings and equipment) | $1.60 |
| Free cash flow | $8.08 |
| Dividends | $1.43 |
| Cash and investments | $8.08 |
| Debt | $34.67 |
| Book value | $76.23 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2016 | $24.12 | $3.65 | $0.84 | $4.19 | — | $33.23 |
| 2017 | $25.96 | $3.53 | $0.81 | $4.12 | — | $37.84 |
| 2018 | $28.01 | $3.74 | $0.82 | $4.84 | — | $40.22 |
| 2019 | $24.69 | $4.05 | $0.88 | $4.57 | — | $43.52 |
| 2020 | $31.01 | $4.88 | $1.10 | $7.54 | — | $55.93 |
| 2021 | $33.66 | $8.51 | $1.68 | $9.66 | — | $63.17 |
| 2022 | $36.15 | $9.64 | $1.52 | $10.04 | — | $68.77 |
| 2023 | $32.15 | $6.38 | $1.86 | $7.78 | — | $72.36 |
| 2024 | $32.39 | $5.29 | $1.89 | $7.18 | — | $68.90 |
| 2025 | $34.31 | $5.05 | $1.61 | $7.35 | — | $74.32 |